Dr John La Marca

Experts / Dr John La Marca

Senior Resarch Officer, Walter and Eliza Hall Institute

Dr John (Eddie) La Marca completed his PhD at La Trobe University, where he studied genes that control stem cell behaviour in Drosophila melanogaster. He then completed post-doctoral work at La Trobe University, researching the genes that regulate tumourigenesis, also using Drosophila melanogaster. He then moved to The Walter & Eliza Hall Institute, where his post-doctoral research explores blood cell and blood cancer development.

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

Oncology

Clinical Articles

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

By Sarah Diepstraten, Dr John La Marca

Clinical Articles

Oncology

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

By Sarah Diepstraten, Dr John La Marca

Dr John La Marca

Senior Resarch Officer, Walter and Eliza Hall Institute

More from this expert

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

Get the app

Site

Company

Connect

Legal

Discover

Healthed

First Healthed Webcast for 2026

An Update on Heart Failure in Primary Care

Tuesday 3rd February, 7pm - 9pm AEDT

Speaker

Prof Andrew Sindone

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital

We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.

Dr John La Marca

Senior Resarch Officer, Walter and Eliza Hall Institute

More from this expert

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

First Healthed Webcast for 2026

An Update on Heart Failure in Primary Care

Tuesday 3rd February, 7pm - 9pm AEDT

Speaker

Prof Andrew Sindone

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital

We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.